Brief: Sinopharm Group Says China National Accord Medicine's Q1 Revenue RMB19,090 Mln
Apr 25 (Reuters) - SINOPHARM GROUP - CHINA NATIONAL ACCORD MEDICINES CORP Q1 REVENUE RMB 19,090 MILLION * SINOPHARM GROUP - CHINA NATIONAL ACCORD MEDICINES CORP Q1 NET INCOME RMB 446 MILLION
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For